% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Camargo:177394,
author = {M. C. Camargo and M. Song and X. Xu and I. Zhao and J. N.
Sampson and A. Etemadi and H. Brenner$^*$ and H.-W. Lee and
B. Trabert and B. Holleczek$^*$ and B. Schöttker$^*$ and K.
Spaid and S. M. Dawsey and S. Lee and T. Shimura and S. K.
Park and R. Malekzadeh and D. Kang and C. S. Rabkin},
title = {{U}rinary estrogen metabolites and gastric cancer risk
among postmenopausal women.},
journal = {Cancer reports},
volume = {5},
number = {7},
issn = {2573-8348},
address = {Medford, MA},
publisher = {Wiley},
reportid = {DKFZ-2021-02486},
pages = {e1574},
year = {2022},
note = {2022 Jul;5(7):e1574},
abstract = {The overall incidence of gastric cancer in women is half
that in men for most global populations. Sex hormone
pathways may be involved in carcinogenesis and estrogens
have been postulated to protect women against gastric
cancer.To evaluate associations of gastric cancer with
estrogen metabolites in postmenopausal women.We performed an
analysis of 233 gastric cancer cases and 281 age-matched
controls from three prospective cohorts and two case-control
studies of early-stage gastric cancer, mainly conducted in
high-risk Asian populations. Fifteen estrogen-parent
(estrone and estradiol) and -metabolite analytes
(2-hydroxyestrone, 2-hydroxyestradiol,
2-hydroxyestrone-3-methyl ether, 4-hydroxyestrone;
4-methoxyestrone, 4-methoxyestradiol, 2-methoxyestrone,
2-methoxyestradiol, estriol, 16α-hydroxyestrone,
16-ketoestradiol, 16-epiestriol, and 17-epiestriol) were
measured in spot urines using liquid chromatography-tandem
mass spectrometry. Odds ratios for association with each
marker were estimated by logistic regression. Heterogeneity
was assessed by Cochran's Q test. Study-specific odds ratios
were pooled by fixed-effects meta-analysis. Urinary levels
of estrogen-related molecules were not associated with
gastric cancer (adjusted odds ratios ranged from 0.87 to
1.27; p-values >.05), with low between-study heterogeneity
(p-values >.1) for all but two metabolites
(2-hydroxyestrone-3-methyl ether and 2-methoxyestradiol).To
date, this is the first comprehensive assessment of
endogenous estrogens with gastric cancer risk in women.
Estrogens do not appear to have an etiologic role in gastric
cancer risk among postmenopausal women. Given the complex
network of sex steroid hormones and their extreme variation
over the lifespan, further evaluation of this hypothesis is
warranted.},
keywords = {estradiol (Other) / estrogens (Other) / estrone (Other) /
gastric cancer (Other) / sex hormones (Other)},
cin = {C120 / C070},
ddc = {610},
cid = {I:(DE-He78)C120-20160331 / I:(DE-He78)C070-20160331},
pnm = {313 - Krebsrisikofaktoren und Prävention (POF4-313)},
pid = {G:(DE-HGF)POF4-313},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:34766475},
doi = {10.1002/cnr2.1574},
url = {https://inrepo02.dkfz.de/record/177394},
}